Page last updated: 2024-08-24

mevastatin and Pachyonychia Congenita

mevastatin has been researched along with Pachyonychia Congenita in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gartner, U; McLean, WH; Smith, FJ; Zhao, Y	1

Other Studies

1 other study(ies) available for mevastatin and Pachyonychia Congenita

Article	Year
Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita. The Journal of investigative dermatology, 2011, Volume: 131, Issue:5 Topics: Anticholesteremic Agents; Cell Line; Down-Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon-gamma; Keratin-6; Lovastatin; Mevalonic Acid; Pachyonychia Congenita; Promoter Regions, Genetic; STAT1 Transcription Factor	2011

Article

Year

Statins downregulate K6a promoter activity: a possible therapeutic avenue for pachyonychia congenita.

The Journal of investigative dermatology, 2011, Volume: 131, Issue:5

Topics: Anticholesteremic Agents; Cell Line; Down-Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interferon-gamma; Keratin-6; Lovastatin; Mevalonic Acid; Pachyonychia Congenita; Promoter Regions, Genetic; STAT1 Transcription Factor

2011